Explore Research Innovation at the David Geffen School of Medicine
UCLA Health / David Geffen School of Medicine (DGSOM) is committed to supporting faculty entrepreneurs to develop innovative technologies to advance biomedical breakthroughs, novel therapeutics and cures for patients. This website is to help aggregate staff, resources, roles and responsibilities for those seeking to learn more about innovation and entrepreneurship within the school and across campus.
The information is broken into two sections, the first showcases opportunities for faculty to apply for financial support, and the second section showcases workshops, resources, and key contacts for DGSOM faculty.
UCLA is No. 1 in the nation when it comes to the number of startup companies launched as a result of campus research, according to the rankings by the Milken Institute, an independent economic think tank based in Santa Monica. This represents a jump of 30 spots since 2006, which was the last time the index was produced. A total of 225 American universities and research institutions were ranked. Among them were UC San Diego (No. 20), UC Davis (No. 41), UC Berkeley (No. 53), UC San Francisco (No. 54), UC Irvine (No. 64), UC Santa Barbara (No. 83), UC Riverside (No. 120) and UC Santa Cruz (No. 152).
Read full story on the UCLA Newsroom
The David Geffen School of Medicine, TDG, Engineering, Physical Sciences and others are participating in a campus wide competition to advance therapeutics, medical devices - diagnostics, and digital health technologies. Apply now for funding to support your commercialization project.